局部晚期直肠癌IMRT使用趋势:NCCN中心2005-2011年分析
该研究基于NCCN结直肠癌数据库,分析了2005至2011年间976例II-III期直肠癌患者的放疗模式。结果显示IMRT使用率从2009年前的<13%增至2010年后的>30%,但机构间差异显著(范围0%-43%)。IMRT与3D-CRT的放疗完成率和完成时间相似。
要点
- IMRT使用率从2009年前的<13%上升至2010年后的>30%,机构间差异大(0%-43%)。
- 与IMRT使用相关的因素包括年龄≥65岁、剂量>50.4 Gy、非裔美国人种族及无经腹手术。
- IMRT与3D-CRT的放疗完成率和完成时间相似,需比较有效性研究评估获益。
核心结论
- 2005-2011年间多数II-III期直肠癌患者接受3D-CRT,但IMRT使用显著增加且机构间差异大。
研究设计与样本
- 基于NCCN结直肠癌前瞻性数据库,纳入2005-2011年间976例接受盆腔放疗的II-III期直肠癌患者,采用多因素logistic回归分析IMRT相关因素。
主要发现
- IMRT使用率从2009年前的<13%增至2010年及以后的>30%,机构间范围0%-43%。
- 与IMRT使用相关的因素包括年龄≥65岁、剂量>50.4 Gy、非裔美国人种族及无经腹手术。
- IMRT与3D-CRT组的放疗完成率和完成时间相似。
临床怎么用
- 在NCCN中心,II-III期直肠癌的IMRT使用呈增加趋势且机构间差异大,临床决策需考虑机构经验和患者因素。
局限性
- 研究仅纳入NCCN中心患者,结果外推需谨慎;为回顾性分析,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Intensity modulated radiation therapy (IMRT) has been rapidly incorporated into clinical practice because of its technological advantages over 3-dimensional conformal radiation therapy (CRT). We characterized trends in IMRT utilization in trimodality treatment of locally advanced rectal cancer at National Comprehensive Cancer Network cancer centers between 2005 and 2011. METHODS AND MATERIALS: Using the prospective National Comprehensive Cancer Network Colorectal Cancer Database, we determined treatment patterns for 976 patients with stage II-III rectal cancer who received pelvic radiation therapy at contributing centers between 2005 and 2011. Multivariable logistic regression was used to identify factors associated with IMRT versus 3-dimensional CRT. Radiation therapy compliance and time to completion were used to compare acute toxicity. RESULTS: A total of 947 patients (97%) received 3-dimensional CRT (80%) or IMRT (17%). Ninety-eight percent of these patients received radiation therapy preoperatively, and 81% underwent definitive resection. IMRT use increased from <13% pre-2009 to >30% in 2010 and thereafter, with significant variability among institutions (range, 0%-43%). Other factors associated with IMRT use included age ≥65 years, dose >50.4 Gy, African-American race, and no transabdominal surgery. Rates of and time to radiation therapy completion were similar between the groups. CONCLUSIONS: Although most patients with stage II-III rectal cancer at queried National Cancer Institute-designated cancer centers between 2005 and 2011 received 3-dimensional CRT, significant and increasing numbers received IMRT. IMRT utilization is highly variable among institutions and not uniform among sociodemographic groups but may be more consistently embraced in specific clinical settings. Given this trend, comparative-effectiveness research is needed to evaluate the benefits of IMRT for rectal cancer.
引用
- Reyngold M, Niland J, Ter Veer A, et al. Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers. Adv Radiat Oncol. 2017. PMID: 29556578. doi:10.1016/j.adro.2017.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。